Article
Secondary progressive in contrast to relapsing-remitting multiple sclerosis patients show a normal CD4+CD25+ regulatory T-cell function and FOXP3 expression.
Journal of neuroscience research - 1 Jun 2006
Venken Koen, Hellings Niels, Hensen Karen, Rummens Jean-Luc, Medaer Robert, D'hooghe Marie B, Dubois Bénédicte, Raus Jef, Stinissen Piet
Abstract excerpt
Accumulating evidence indicates an immunosuppressive role for CD4(+)CD25(+) regulatory T cells (Tregs) in autoimmune diseases. Although an impaired Treg function in patients with relapsing-remitting multiple sclerosis (RR-MS) has been reported recently, no information is available so far about Treg function in the progressive stage of the disease. In the present study, the phenotypic and functional...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
